SELLAS Life Sciences Group, Inc.: accounts_payable
| Value | {"amount": 2305000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2025-09-30) |
| Status | current |
| Entity | SELLAS Life Sciences Group, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:26:31.937297+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/8de3e7bf-bba8-4d5a-a2a4-65e61bc9442e
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001390478-25-000020 · Open the official SEC filing →Retrieved: 2026-08-19T13:26:31.937297+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001390478/accounts-payable/2025-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/8de3e7bf-bba8-4d5a-a2a4-65e61bc9442e
History
- no predecessors — first report